Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-FICB vs PENG Block for Spinal Positioning in Femur Fracture
NCT06568770Phase 3Recruiting
- Sponsor
- Sahiwal Medical College
- Start
- Jul 2024
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of bupivacaine in Femur fracture (2 arms), sponsored by Sahiwal Medical College. Primary endpoint: Ease Of Spinal Positioning at 20 minutes. Started Jul 2024; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
Femur fracture
Beyond the preview
Go deeper on NCT06568770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06568770.